|
|
|
* - may be subscription-only |
|
|
- Artiva Biotherapeutics: Expands Board of
Directors With Appointment of Dan Baker, M.D. More
- Epirium Bio: First Participants Dosed in Phase 1
Clinical Trial in Healthy Volunteers, Evaluating
MF-300, a First-In-Class, Oral 15-PGDH Enzyme
Inhibitor, for the Treatment of Sarcopenia More
- Modular Medical: BSI Group as Trusted Body for CE
Mark Clearance More
- Tyra Biosciences: Appointment of Adele Gulfo to
Board of Directors More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
|
- IQHQ’s $900M Raise Aims to Jump-Start Leasing at
Megaprojects More*
- San Diego's Vacant Life Science Labs and Offices
Continue to Grow. Will the Glut Peak in 2025? More*
- Top 25 Biotech Companies Heading Into 2025 More
|
|
|
- Resolved Transthyretin Protein Structures Could
Lead to New Therapies for Progressive Amyloidosis More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
Spotlight:
|
|
Access research-ready vivaria near you -
10 locations
Schedule
A Tour
|
|
|
Section
Sponsor:
|
 |
|
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:San Diego Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
|
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- OPPORTUNITY: Senior Director, Integrated Marketing
& Communications - Remote More
- OPPORTUNITY: Clinical Development Leader - New York,
NY More
- OPPORTUNITY: Sales Executive - Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America - Remote More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
